Parkinson's News Today Home | Parkinson's News Today
WEBSep 18, 2024 · New method may identify younger people at risk for Parkinson’s. A new method for detecting toxic protein clumps of alpha-synuclein in skin cells may help diagnose Parkinson’s disease up to two decades before motor symptoms appear, according to a …
A Potential Parkinson’s Treatment Has Promising Results
WEBJun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
Q&A: New tech could improve care for Parkinson's patients
WEB16 hours ago · The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and monitoring of the neurological disease seems many decades behind. Clinicians ...
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
WEBSep 26, 2023 · Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
WEBMar 11, 2024 · Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.
Parkinson's News -- ScienceDaily
WEBHeadlines. Smartwatches Offer Window Into Parkinson's Disease Progression. June 12, 2024 — New research adds to growing evidence that widely used and user-friendly consumer devices, in this...
Parkinson's disease - Latest research and news - Nature
WEB5 days ago · Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
Newly discovered trigger for Parkinson's may lead to better …
WEBMedical News Today September 26, 2023 Researchers have discovered that two genes may disrupt the function of synapses between dopaminergic neurons before the nerve cells themselves are affected in Parkinson's disease.
New Findings About Key Pathological Protein in Parkinson’s …
WEBDec 18, 2023 · A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.
Phase 3 trials of tavapadon for Parkinson's motor symptoms near …
WEBNov 7, 2023 · An ongoing and global Phase 3 clinical trial program for oral tavapadon, a selective dopamine receptor agonist aiming to improve motor function in people with Parkinson’s disease, expects to release study findings next year.
Skip to content